Interpace Biosciences, Inc.
IDXG
$1.14
-$0.03-2.56%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -58.23% | -58.01% | -60.25% | -49.75% | -27.55% |
| Total Receivables | 68.26% | 50.99% | 12.24% | 6.17% | 0.91% |
| Inventory | -1.30% | 11.62% | 4.59% | -1.70% | 0.25% |
| Prepaid Expenses | -9.32% | 0.23% | 3.89% | 18.35% | 51.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -8.33% | 0.00% | -92.15% | -91.52% | -96.47% |
| Total Current Assets | 13.02% | -2.87% | -21.65% | -24.58% | -14.29% |
|
|
|||||
| Total Current Assets | 13.02% | -2.87% | -21.65% | -24.58% | -14.29% |
| Net Property, Plant & Equipment | 12.06% | 5.26% | 2.41% | -4.39% | -9.08% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 12.78% | -1.48% | -18.63% | -23.52% | -17.92% |
|
|
|||||
| Total Accounts Payable | 7.45% | 25.81% | 4.26% | -13.84% | 47.05% |
| Total Accrued Expenses | 10.65% | 19.15% | 14.86% | 15.93% | -61.95% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -14.68% | 1,347.58% | 265.57% | 187.13% | 77.94% |
| Total Finance Division Other Current Liabilities | -32.08% | -54.82% | -48.85% | -44.90% | -37.49% |
| Total Other Current Liabilities | -32.08% | -54.82% | -48.85% | -44.90% | -37.49% |
| Total Current Liabilities | -7.18% | 52.30% | 40.29% | 36.98% | -19.93% |
|
|
|||||
| Total Current Liabilities | -7.18% | 52.30% | 40.29% | 36.98% | -19.93% |
| Long-Term Debt | -- | -- | -- | -87.94% | -62.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -19.63% | -23.59% | -21.87% | -22.25% | -20.35% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.89% | 5.62% | 1.02% | -1.48% | -4.81% |
| Total Liabilities | -23.10% | -17.14% | -19.45% | -16.10% | -31.97% |
|
|
|||||
| Common Stock & APIC | 24.75% | 0.18% | 0.22% | 0.27% | 0.34% |
| Retained Earnings | 2.77% | 1.89% | 1.13% | 0.37% | 2.78% |
| Treasury Stock & Other | -2.29% | -2.45% | -1.96% | -1.96% | -1.62% |
| Total Common Equity | 96.01% | 7.97% | 5.11% | 2.23% | 11.94% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 96.01% | 7.97% | 5.11% | 2.23% | 11.94% |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 75.37% | 30.96% | 20.29% | 8.73% | 45.56% |
|
|
|||||